| Literature DB >> 33143928 |
Nick Reed1, Janos Balega2, Tara Barwick3, Lynn Buckley4, Kevin Burton5, Gemma Eminowicz6, Jenny Forrest7, Raji Ganesan8, Rosie Harrand9, Cathrine Holland10, Tamara Howe11, Thomas Ind12, Rema Iyer13, Sonali Kaushik14, Robert Music15, Azmat Sadozye9, Smruta Shanbhag16, Nadeem Siddiqui5, Sheeba Syed17, Natalie Percival18, Natasha Lauren Whitham19, Andy Nordin20, Christina Fotopoulou6.
Abstract
Cervix cancer in many countries is declining and screening programmes and immunisation will reduce the incidence in the next few decades. This guideline attempts to cover management of invasive disease reflecting diagnosis and imaging including new imaging and sentinel lymph node biopsies. Smaller volume disease is usually managed surgically whereas advanced disease is treated with (chemo)- radiation. It also includes discussion of fertility sparing procedures. Practices are changing frequently for all aspects of care usually in attempts to reduce complications and improve quality of life. The management of advanced disease is treated by chemotherapy and the use of newer agents is also discussed. Other sections discuss specialist situations such as cancer in pregnancy, rare cervical tumours, late effects and supportive measures and fertility preserving approaches.Entities:
Keywords: Cervical cancer; Chemotherapy; Fertility preservation; Imaging; Pathology; Quality of life; Radiotherapy; Surgery
Mesh:
Year: 2020 PMID: 33143928 DOI: 10.1016/j.ejogrb.2020.08.020
Source DB: PubMed Journal: Eur J Obstet Gynecol Reprod Biol ISSN: 0301-2115 Impact factor: 2.435